How Concerned Should Income Investors Be About Pfizer's Dividend?
finance.yahoo.com · 2026-09-12
Pfizer has a huge 6% yield and a payout ratio well over 100%, yet the company is still maintaining the dividend.
TickrTrends take: Pfizer's dividend sustainability has become a focal point for income-focused investors, particularly given the company's current overvalued status according to TickrTrends metrics. For valuation-conscious investors, the divergence between the stock's elevated valuation and dividend expectations warrants attention, as overvaluation can constrain future capital appreciation while dividend yield becomes a larger component of total returns. In the Healthcare sector, where PFE operates, dividend coverage relative to earnings deserves monitoring to assess whether current payouts remain supported by underlying business fundamentals as the company navigates its valuation premium.
Read the full story at finance.yahoo.com →
Is PFE undervalued? See TickrTrends' fair value analysis →